The first superoxide dismutase (SOD) was discovered half a century ago ([@bib119]). It was subsequently well established that SODs are the first line of defense against oxygen free radicals, and the vast majority of organisms that live in the presence of oxygen express at least one SOD. Three classes of SOD have evolved in various organisms possessing different catalytic metal ions: Cu/Zn SODs, Mn SOD/Fe SODs, and Ni SODs (Table S1; [@bib108]; [@bib18]; [@bib24]; [@bib195]; [@bib93]; [@bib173]; [@bib46]; [@bib59]; [@bib5]; [@bib95]; [@bib13]). In addition to requirements for metal ion cofactors, SOD enzymes also have distinct subcellular localizations. Eukaryotes only express Cu/Zn SODs (in the cytoplasm and extracellularly) and Mn SODs (in the mitochondria; [@bib122]).

Chemically, the dismutase activity of SODs accelerates the reaction of the superoxide anion (O~2~^•−^) with itself to form hydrogen peroxide (H~2~O~2~) and oxygen (2O~2~^•−^+2H^+^ → H~2~O~2~+O~2~; [@bib62]). Superoxide is a negatively charged free radical formed through a single electron donation to oxygen ([@bib74]). It is only moderately reactive by itself ([@bib197]), but it participates in several reactions yielding a variety of reactive oxygen species (ROS) and reactive nitrogen species (RNS) such as H~2~O~2~ and peroxynitrite (ONOO^−^), from which many additional secondary radical species can be generated ([Fig. 1](#fig1){ref-type="fig"}; [@bib171]; [@bib9]; [@bib62]). By controlling O~2~^•−^, SODs also control the concentrations of these species. The SOD-catalyzed dismutation reaction is extremely efficient, occurring at the almost diffusion-limited rate of ∼2 × 10^9^ M^-1^·s^-1^, which is ∼10^4^ times the rate constant for spontaneous dismutation ([@bib61]).

![**Reactions and transformations of the superoxide anion.** SOD enzymes catalyze the dismutation of superoxide (O~2~^•-^), generating hydrogen peroxide (H~2~O~2~). The catalase (CAT), glutathione peroxidases (GPXs), and PRXs convert H~2~O~2~ into water. H~2~O~2~ can react with redox-active metals (e.g., iron) to generate the hydroxy radical (OH^•^) through the Fenton/Haber-Weiss reaction. The reaction between O~2~^•-^ and nitric oxide (NO^•^) produces ONOO^−^, whose decomposition in turn gives rise to some highly oxidizing intermediates including NO~2~^•^, OH^•^, and CO~3~^•-^ as well as, ultimately, stable NO~3~^−^. Therefore, raised O~2~^•-^ levels can also decrease NO^•^ bioavailability and generate ONOO^−^ toxicity. O~2~^•-^ by itself can reduce ferric iron (Fe^3+^) to ferrous iron (Fe^2+^) in iron--sulfur centers of proteins, leading to enzyme inactivation and concomitant loss of Fe^2+^ from the enzymes, which in turn fuels Fenton chemistry. The protonation of O~2~^•-^ can form the more reactive hydroperoxyl radical (HO~2~^•^).](JCB_201708007_Fig1){#fig1}

In respiring organisms, many spontaneous and enzymatically catalyzed reactions can give rise to O~2~^•−^ ([Fig. 2](#fig2){ref-type="fig"}). These include the mitochondrial electron transport chain (ETC), the plasma membrane--associated NADPH oxidase complex (NOX), the cytosolic xanthine oxidase, and the cytochrome p450 monooxygenases, which are present mainly in the ER ([@bib78]). Despite their potential toxicity, O~2~^•−^ and some of its derivatives, especially H~2~O~2~, are also signaling molecules that mediate a variety of biological responses such as cell proliferation, differentiation, and migration ([@bib78]). Furthermore, evidence is presented that burst production of ROS such as O~2~^•−^ and/or H~2~O~2~ is an important component of the pathogen defense mechanism ([@bib36]; [@bib72]; [@bib25]). Superoxide does not readily pass though cell membranes and is relatively short lived; thus, it presumably acts where it is produced. In contrast, H~2~O~2~ is uncharged, more stable, and can traverse membranes freely, making it a more versatile signaling molecule ([Fig. 2](#fig2){ref-type="fig"}; [@bib20]; [@bib78]). The presence of specific SOD isoforms in distinct subcellular compartments highlights the need for a tight control of ROS homeostasis and suggests a role for ROS in signaling between compartments. For example, changes in SOD activity in a particular compartment could lead to production of an H~2~O~2~ concentration gradient, leading to an H~2~O~2~ flux and subsequently activation of particular redox-sensitive pathways. In this review, we will discuss the functions of SODs by focusing principally on findings arising from the study of SOD mutants in model organisms.

![**SOD-dependent ROS signaling in mammalian cells.** In aerobic organisms, many processes produce O~2~^•-^, including cytosolic xanthine oxidase (OX), the cytochrome P450-monooxygenases (CYP) in the ER, the mitochondrial ETC, and NADPH oxidase (NOX). NOX is a membrane-bound enzyme complex that can be found in the plasma membrane as well as within intracellular membrane structures or vesicles ([@bib120]). O~2~^•-^ produced by the plasma membrane--bound NOX (e.g., NOX2) can act both intra- and extracellularly. H~2~O~2~ produced by SOD3 outside the cell can transverse into the cell interior in part through aquaporin channels to initiate intracellular signaling, whereas O~2~^•-^ could influx through the chloride channel-3 ([@bib56]). The intracellular NOX complexes produce ROS in the lumen of a vesicular compartment, where ROS acts locally or from which it enters the cytosol ([@bib15]). H~2~O~2~ has been implicated in ROS signaling through oxidative modification of critical redox-sensitive cysteines in signaling proteins. The relatively well-recognized targets of ROS signaling include protein phosphatases (PTPs), nonreceptor protein tyrosine kinases (PTKs), protein kinase C (PKC), mitogen-activated protein kinases (MAPKs), and transcriptional factors (TFs). The signaling function of O~2~^•-^ is yet largely uncharacterized. In *C. elegans*, it was shown that mitochondrial ROS act by signaling in part through the intrinsic apoptotic pathway, likely via H~2~O~2~, triggering processes that promote longevity ([@bib205]). Compartmentalization of different forms of SOD provides an important mechanism for fine spatial control of ROS homeostasis and signaling, whose exact significance remains to be understood. CAT, catalase; GPX, glutathione peroxidase.](JCB_201708007_Fig2){#fig2}

Limiting simple chemical ROS toxicity {#s02}
=====================================

Although O~2~^•−^ is generally not considered to be a strongly oxidizing agent, it is still potentially toxic. In particular, O~2~^•−^ can oxidize iron--sulfur clusters in proteins (e.g., the Krebs cycle and cytosolic enzymes aconitase), resulting in cluster degradation and loss of the catalytic iron and hence enzymatic activity ([@bib111]; [@bib88]). Furthermore, the iron atom released in this process can directly reduce H~2~O~2~ to generate the highly toxic hydroxyl radical (OH^•^; [Fig. 1](#fig1){ref-type="fig"}; [@bib111]). In organisms ranging from bacteria to mice, loss of SOD activity is associated with increased levels of oxidative damage such as membrane lipid peroxidation, protein carbonylation, and DNA breakage ([@bib44]; [@bib194]; [@bib48]; [@bib204]). This indicates that insufficient removal of endogenously generated superoxide is indeed deleterious. In addition to the toxicity of superoxide itself, this is likely because of the generation of ONOO^−^ when O~2~^•−^ reacts with nitric oxide (NO^•^; [@bib137]). Decomposition of ONOO^−^ also results in the formation of some very reactive species such as OH^•^, NO~2~^•^, and CO~3~^•-^ ([@bib184]). The SODs are the only enzymes that can prevent ONOO^−^ formation by removing O~2~^•−^. In fact, ONOO^−^ accumulation resulting from inefficient O~2~^•−^ removal in the mitochondria can significantly impair mitochondrial function and could thus contribute to the early lethality of *Sod2* null mice ([@bib16]) as will be discussed.

Cysteine-mediated redox signaling {#s03}
=================================

Besides potentially evoking oxidative and nitrosative stress, the loss of SODs might also be toxic by perturbing ROS signaling by lowering H~2~O~2~ concentration. Indeed, the best-known mechanism of how ROS act as signaling molecules involves H~2~O~2~-mediated oxidation of key cysteines within proteins that possess regulatory functions ([@bib53]). The thiol (RSH) groups of cysteines, including those at active sites, can exist in different redox states ([@bib140], [@bib141]). Oxidation of the reactive cysteine residues can result in a wide range of posttranslational modifications (e.g., *S*-glutathiolation, sulfenic acid, and disulfide formation), which can produce structural changes that are sufficient to alter protein function, stability, and subcellular localization ([@bib149]). Also, importantly, the reactivity of any cysteine thiol group is greatly influenced by the protein context, meaning that some cysteine residues are more susceptible to oxidation than others, which provides a molecular basis for selectivity and specificity in redox signaling ([@bib116]; [@bib35]; [@bib115]). Like cysteines, methionines also contain reactive sulfur atoms that are susceptible to reversible redox modifications and thus may also mediate redox signaling ([@bib42]).

One widely studied class of targets of redox regulation is the protein tyrosine phosphatase (PTPs) family. Acting in concert with receptor tyrosine kinases, PTPs play a regulatory role in many cellular functions such as responses to growth factor signaling ([@bib187]). The active site of PTPs contains an essential cysteine residue that is in the thiolate anion form (Cys-S^−^) at neutral pH and is therefore highly susceptible to oxidation ([@bib185]; [@bib149]). Oxidation of the active-site cysteine leads to PTP inactivation, which is generally reversible and thus transient ([@bib37]; [@bib149]).

H~2~O~2~ has also been shown to play a role in phosphorylation-dependent signaling via activating intracellular tyrosine kinases. In this case, specific oxidation of the cysteine sulfhydryl (SH) group induces conformational changes that lead to kinase activation. For example, the first discovered oncogene Src, which is such a nonreceptor tyrosine kinase, is well demonstrated to be redox sensitive ([@bib67]; [@bib32]). Furthermore, serine/threonine-specific protein kinases MAPK and Akt, both important effectors of growth factor receptor signaling pathways, have been shown to undergo direct redox activation ([@bib131]; [@bib32]). Finally, transcriptional factors constitute an important class of ROS-responsive proteins. Those include NF-κB, AP-1, H1F-1a, p53, and upstream stimulatory factor (USF), with active sites that contain low-pKa cysteine residues, whose oxidative modifications cause either their activation (e.g., p53, HIF-1, HSF1, and NRF2) or inactivation (e.g., USF; [Fig. 2](#fig2){ref-type="fig"}; [@bib3]; [@bib14]).

Oxidation of cysteine thiols by H~2~O~2~ is a two-electron reaction that leads to the production of sulfenic acids, whereas one-electron oxidation by superoxide and the OH^•^ leads to thiyl radicals ([@bib188]). It is postulated that cysteine thiyl radicals can undergo intramolecular hydrogen transfer reactions with the surrounding amino acids, causing protein damage ([@bib158]). They are also a potential source for *S*-nitrosylation, *S*-glutathiolation, and sulfenic acid production regulation. But little is known about the in vivo role of cysteine thiyl radicals in redox signaling ([@bib159]).

Although the removal of H~2~O~2~ is highly regulated by numerous enzymatic systems (e.g., catalase, glutathione peroxidases, and peroxiredoxins \[Prxs\]), this might be for the purpose of regulating its signaling activity rather than its potential toxicity. This is suggested by the observation that there is little phenotypic effect of the loss of catalase in mice. Catalase is normally found at high concentrations in peroxisomes, where H~2~O~2~ is mainly produced by the β oxidation of fatty acids and might have no signaling role ([@bib160]).

Additional aspects of the diverse role of SODs in the regulation of redox signaling {#s04}
===================================================================================

Among ROS, superoxide and H~2~O~2~ have the most favorable properties to operate as signaling molecules. However, H~2~O~2~ has been given the most attention. First, it is relatively stable and can cross through cellular membranes, implicating the ability to deliver a redox signal to distant targets ([@bib12]). Second, its enzymatic production and removal potentially provides site and time specificity for its action ([@bib60]; [@bib54]; [@bib115]). There are also some practical reasons for why H~2~O~2~ is best understood. For example, it is very difficult to target O~2~^•−^ specifically (e.g., manipulations of O~2~^•−^ levels will also affect H~2~O~2~), but many more tools are available to modify steady-state levels of H~2~O~2~, such as exposure of culture cells to H~2~O~2~ directly or treatment with the antioxidant *N*-acetyl cysteine, which impacts mainly H~2~O~2~. Note that superoxide production can also be tightly regulated, such as for example its production by NADPH oxidases ([@bib10]). If, as some research suggests, ROS signaling is largely elicited by a transient burst of ROS generation (part of the mechanisms conferring signal specificity; [@bib183]), O~2~^•−^ should be able to oxidize thiols on regulatory proteins in the immediate vicinity of its point of generation despite its relative instability and poor diffusibility ([@bib20]). Still, relatively little is known about O~2~^•−^ signaling ([@bib60]). Interestingly, it has been shown that O~2~^•−^ participates in major epigenetic processes such as DNA methylation, histone methylation, and histone acetylation ([@bib2]). O~2~^•−^ has also been shown to regulate autophagy ([@bib27]). Cells lacking functional ETC showed reduced autophagy during starvation, indicating ROS of mitochondrial origin playing a major role ([@bib109]).

The study of SODs helps clarify the signaling roles of superoxide and H~2~O~2~. For example, the SOD1 inhibitor tetrathiomolybdate (ATN-224) protects PTPs from oxidation, and this, in turn, attenuates growth factor--mediated phosphorylation of ERK1/2 in endothelial and tumor cells ([@bib94]). The implication is that it is H~2~O~2~ rather than superoxide that mediates these effects ([@bib94]). Of note, however, is that ATN-224 was shown to increase O~2~^•−^ but also elevates intracellular H~2~O~2~ levels, which was interpreted to suggest an unconventional function of SOD1, though this remains to be fully elucidated ([@bib68]). Overexpression of human SOD1 in mouse NIH 3T3 fibroblasts enhances vascular endothelial growth factor expression, which can be suppressed by overexpression of human catalase, again pointing to a role of H~2~O~2~ in these phenomena ([@bib115]). Similarly, SOD2 overexpression in human fibrosarcoma mitochondria leads to phosphatase and tensin homolog (PTEN) inactivation and subsequent activation of PI3K-Akt signaling. This can be inhibited by overexpression of catalase in the cytosol or mitochondria ([@bib30]).

How closely is ROS signaling controlled by SODs? There is consensus that ROS fulfills its signaling function at low or moderate levels. One mechanism that has been proposed for how ROS signaling specificity is achieved is confinement of the sources of ROS, such as SODs and NOXs, close to their intended targets ([@bib126]). Several lines of evidence further suggest that NOX ROS production may be localized proximal to signal proteins (e.g., PTPs), and such spatial restriction of ROS signal is required for effective oxidation of specific redox-sensitive proteins ([@bib190]; [@bib26]). Thus, the compartmentalization of SODs is likely critically important for spatial control of ROS-based signaling. Altered SOD expression or activity changes are observed in various pathological conditions such as, for example, cancer and amyotropic lateral sclerosis (ALS; [@bib38]; [@bib151]). These changes may not only perturb protection from potential ROS toxicity but also misregulate many redox-sensitive pathways that contribute to disease outcome.

Finally, it is noteworthy that at neutral pH, the rate constant for thiol oxidation by superoxide (\<10^3^ M^−1^ s^−1^) is far lower than the rate constant for SODs (\>10^9^ M^−1^s^−1^; [@bib60]). Similarly, the redox-active thiols in some signaling proteins like the phosphatases Cdc25B and PTB1B were found to have a lower reactivity toward H~2~O~2~ (i.e., the rate of oxidation by H~2~O~2~) than H~2~O~2~ scavengers, especially Prxs ([@bib197]; [@bib115]). The kinetic disadvantage of protein thiol oxidation appears difficult to reconcile with them being a direct sensor and target of ROS signal. Explaining how poorly reactive targets outcompete ROS scavengers in reacting with ROS, there are currently two main schools of thought. The floodgate hypothesis posits that oxidation of redox-regulated target proteins requires the inactivation of Prxs, which allows for local accumulation of a sufficiently high concentration of H~2~O~2~, resulting in a temporal oxidation of target thiols of signaling pathways. The redox relay model proposes that thiol peroxidases, in particular Prxs, are the initial recipients of H~2~O~2~ and subsequently transfer redox equivalents to the end targets ([@bib147]; [@bib172]). Clarification of how each antioxidant system and their subcellular localization play into the mechanisms of ROS signaling is fundamental to better understanding ROS signaling and modulation of ROS-dependent signaling pathways.

Lastly, although this review focuses on animals, a study in yeast reveals how highly specifically SODs can act in signaling ([@bib148]). It was shown that active SOD1 enzyme is required for glucose repression of respiration by binding to a C-terminal degron of Yck1p/Yck2p (two casein kinase 1-γ \[CK1γ\] homologues). This binding results in a very localized rise in H~2~O~2~ levels, which stabilizes the CK1γ kinases, whose activity ultimately results in respiratory repression ([@bib148]).

Role of SODs in RNS control and signaling {#s05}
=========================================

Like ROS, RNS, including NO^•^, NO~2~, ONOO^−^, and others, are reactive molecules that are both functionally important and potentially dangerous. NO^•^ is the main RNS and the primary source of all other RNS ([@bib1]). Superoxide can directly react with NO^•^ to form ONOO^−^ ([Fig. 1](#fig1){ref-type="fig"}). At physiological pH, the direct biradical reaction of NO^•^ with O~2~^•−^ proceeds approximately three times faster than the decomposition of O~2~^•−^ by SODs ([@bib9]), which might be one of the reasons why SODs (especially SOD1, which acts in the largest compartment, comprising cytoplasm and mitochondrial intermembrane space) are so abundant ([@bib24]; [@bib7]). Chemically, NO^•^ is not intrinsically more reactive than oxygen, nor is it highly toxic by itself. However, ONOO^−^ is both a strong oxidant and a nitrating agent toward a wide range of macromolecules. Moreover, it is considered to be relatively stable under physiological conditions and can diffuse across several cell diameters, making it far more toxic ([@bib179]).

NO^•^ is an important signaling molecule modulating diverse physiological processes such as vasodilation, neurotransmission, and the immune response. Thus, by controlling the level of O~2~^•−^ available to react with NO^•^, SODs also preserve the physiological functions of NO^•^. For example, in the blood vessels of mammals, NO^•^ produced by endothelial cells is a vasodilator of the underlying smooth muscles ([@bib211]). It diffuses from the endothelium into the subjacent vascular smooth muscle cells, where it activates guanylate cyclase to increase synthesis of cyclic guanosine monophosphate. This in turn activates cyclic guanosine monophosphate--dependent protein kinases, leading to muscle relaxation. SOD3, the extracellular matrix SOD isoform, inhibits inactivation of vascular NO^•^ by scavenging O~2~^•−^, and thus it plays an essential role in maintaining proper vascular tone and blood pressure ([@bib65]).

The biology of SOD in model animals {#s06}
===================================

Several genetic tools have been created in model organisms that have allowed for the study of the roles of SOD function and ROS metabolism in vivo. In this section, we discuss the findings in three major model organisms: *Caenorhabditis elegans*, *Drosophila melanogaster*, and mouse.

C. elegans {#s07}
----------

In *C. elegans*, five genes encode SODs: *sod-1* to *sod-5*. SOD-1, SOD-4, and SOD-5 are Cu/Zn SODs, whereas SOD-2 and SOD-3 are Mn SODs (Table S1; [@bib92]; [@bib204]; [@bib41]). SOD-1 itself contributes almost 80% of the total *sod* mRNA expression as well as 80% of the total SOD activity in *C. elegans* ([@bib41]). The fact that control of superoxide and peroxide levels is spread over five different SODs with different properties, subcellular distributions, and possibly tissue distributions makes *C. elegans* a particularly good model to explore the variety of biological roles of the SODs.

### Cellular and subcellular patterns of expression of SODs in *C. elegans* {#s08}

SOD-1 and SOD-5 are predicted to be intracellular cytoplasmic Cu/Zn SODs ([@bib104]; [@bib92]). SOD-4 is predicted to be an extracellular membrane--bound Cu/Zn SOD, which exists in two different forms arising from alternative splicing, although neither form has been directly detected ([@bib63]). SOD-1 appears expressed in the cytoplasm of most cells of the worm ([@bib41]; [@bib202]). SOD-5 expression has been detected in the cytoplasm of a small subset of neurons ([@bib41]). However, given that *sod-5* is an inducible *sod* (see below) this may not reflect the complete pattern of expression ([@bib41]).

SOD-2 and SOD-3 are very similar in amino acid sequence and are predicted to be mitochondrial Mn SODs ([@bib85]; [@bib76]; [@bib41]; [@bib81]). Although the two proteins may be coexpressed in the same tissue, it is unclear whether they are colocalized to the same cells, and if so, to the same mitochondria ([@bib76]; [@bib41]). Furthermore, the interpretation of the expression of *sod-3* is complicated by the fact that *sod-3* is inducible. Interestingly, SOD-2 and SOD-3 have been reported to localize in mitochondria at the site of the supercomplex I:III:IV of the ETC. This raises the possibility that these SODs could participate in detoxifying O~2~^•−^ right at the site where it is produced ([@bib178]).

### Induction of *sod* genes in *C. elegans* {#s09}

The expression of both of the two major *sod* genes, *sod-1* and *sod-2*, has been found to be mildly up-regulated by oxidative stress ([@bib181]; [@bib204]; [@bib121]) and possibly by the loss of other *sod* genes ([@bib191]; [@bib202]; [@bib6]). However, the findings about *sod-1* and *sod-2* up-regulation are conflicting, and the conditions under which the studies were done vary greatly. For example, to induce oxidative stress, the prooxidant paraquat (PQ) has been used at concentrations ranging from 0.1 mM to 100 mM. In WT *C. elegans*, there is little to no expression of *sod-3* and *sod-5* under normal conditions ([@bib79]; [@bib41]). They are thus unusual SOD isoforms in that they are strictly inducible. Many environmental conditions, in particular stresses, and genetic mutations have been shown to induce *sod-3* transcription ([@bib52]; [@bib80]; [@bib201]; [@bib76]; [@bib198]; [@bib40]; [@bib71]; [@bib49]; [@bib174]; [@bib178]; [@bib170]; [@bib133]; [@bib146]; [@bib200]). However, the importance of *sod-3* up-regulation for resistance to most of these stresses has not been established (see text box for discussion of aging). One notable exception is resistance to *Enterococcus faecalis*, which requires *sod-3* ([@bib25]). *sod-5,* which is also induced by several conditions, has been studied less extensively ([@bib41]; [@bib49]; [@bib174]; [@bib170]).

#### SODs and longevity in worms and flies {#s10}

The Free Radical Theory of Aging, also known as the Oxidative Stress Theory, proposes that free radicals including ROS are toxic molecules that produce oxidative damage to cellular constituents ([@bib73]; [@bib169]). Over time, the accumulation of this oxidative damage contributes to or may even cause aging. Given this proposed link between ROS and aging as well as the direct role SODs play in regulating ROS, it is not surprising that the phenotype that has been most studied for the *sod* genes in both *C. elegans* and *Drosophila* is aging. In *C. elegans*, most studies have focused on the effects of *sod* knockout mutants. Aging phenotypes have only been reported for *sod-1* and *sod-2*, and only a subset of studies that examined their lifespan found any effect. *sod-1* mutants were found to be slightly short lived ([@bib41]; [@bib202]), whereas surprisingly, *sod-2* mutants have been found to be long lived ([@bib191]; [@bib40]; [@bib203]).

Several groups have also combined *sod* mutations with other long-lived mutants and examined the effects on lifespan. The increase in *sod* levels reported for many long-lived mutants has been shown repeatedly not to be necessary for their longevity ([@bib204]). This is especially striking for the case of *sod-3* and *daf-2*. Indeed, *sod-*3 is strongly up-regulated in *daf-2* mutants ([@bib79]), but knocking down *sod-3* does not suppress *daf-2* longevity ([@bib76]; [@bib41]); in fact, it can actually lengthen it ([@bib81]).

Another key finding is that increased sensitivity to ROS does not shorten lifespan. RNAi knockdown of *sod-2* leads to a measurable increase in ROS sensitivity but increases lifespan ([@bib204]). Overexpression of *sod-1*, against expectation, can also lead to ROS hypersensitivity and an extended lifespan ([@bib41]). Most strikingly, the quintuple *sod* knockout, which is hypersensitive to ROS as well as to other stressors, has a normal lifespan ([@bib192]). A lack of correlation has also been observed by combining *sod* mutations with other mutations that affect lifespan (for examples, see [@bib157] and [@bib43]).

In *Drosophila*, mutation of any of the *Sod*s leads to ROS sensitivity and a shortened lifespan, so there has been a major effort by several laboratories to determine whether overexpression of SODs could be beneficial for lifespan. Indeed, lifespan-lengthening effects were observed in several overexpression models. For example, using P-element--mediated introduction of DNA, transgenic flies overexpressing both *Sod1* and catalase were observed to have an increased lifespan and reduced oxidative damage, whereas overexpression of either enzyme alone had no effect ([@bib135]). Using a different transgenic system that used FLP recombinase to mediate overexpression of transgenes, it was observed that overexpression of either *Sod1* or catalase conferred protection to H~2~O~2~, but only *Sod1* overexpression could increase lifespan in some lines ([@bib176]). Another study used the GAL4-UAS system to overexpress human SOD1 specifically in motor neurons and observed both an increased protection from oxidative stress and an extension of lifespan ([@bib139]). Overexpression of *Sod2* has also been found to increase lifespan ([@bib177]). However, for every study that found an effect on lifespan, there appears to be an equal number of studies that found no effect, even in cases where an increase in oxidative stress resistance was observed (for examples, see ([@bib164], [@bib136], [@bib8], and [@bib127]). Thus, it appears that increasing SOD activity can increase stress resistance and lifespan in some experimental contexts, but it is not sufficient. Other experimental and/or genetic factors must also be necessary to achieve lifespan extension.

Collectively, studies of the SODs in both *C. elegans* and *Drosophila* do not lend support to the oxidative stress theory of aging. Indeed, measurable increases in ROS do not necessarily decrease lifespan and can even lengthen it. In fact, in *C. elegans*, conditions of increased ROS generation such as ETC dysfunction, loss of *sod-2*, PQ treatment, and reduced glucose metabolism were shown to promote longevity ([@bib161]; [@bib45]; [@bib196]). The elements that were demonstrated to be necessary for the longevity phenotypes include the intrinsic apoptosis signaling pathway, which is stimulated by ROS, and the mitochondrial unfolded protein response, which is required for the survival of worms with damaged mitochondria ([@bib83]; [@bib205]). Whether some of the effects on aging could be attributed to phenomena akin to mitohormesis ([@bib150]) could not be discussed because of space constraints.

### ROS sensitivity of *C. elegans sod* mutants {#s11}

Several studies have examined the ROS sensitivity of *sod* mutants. The consensus seems to be that loss of the major *sod* genes *sod-1* or *sod-2* leads to hypersensitivity to oxidative stress. For example, *sod-1* mutants are hypersensitive to 0.1 M PQ ([@bib202]), RNAi knockdown of either *sod-1* or *sod-2* leads to hypersensitivity to 4 mM PQ ([@bib204]), and knockouts of either *sod-1* or *sod-2* (but not other *sod* genes) are sensitive to 40 mM PQ ([@bib41]). Similarly, knockout of either *sod-1* or *sod-2* leads to sensitivity to both 4 mM PQ and 240 µM juglone ([@bib191]). Finally, quintuple knockout mutant animals lacking all the *sods* are extremely hypersensitive to PQ and juglone as well as to other stresses such as osmotic stress, extreme heat, and cold ([@bib192]). In contrast with *sod-1* and *sod-2*, loss of *sod-3* leads only to very mild hypersensitivity to PQ, and loss of *sod-4* or -*5* do not lead to hypersensitivity to either PQ or juglone ([@bib191]). Given the link between ROS damage and aging, several studies have examined how the *sod* mutations affect lifespan (see text box).

### Roles of SOD isoforms in ROS signaling in *C. elegans* {#s12}

Although a role for ROS in signaling has been well established, it has not yet been studied extensively in *C. elegans*. However, there are some observations from studies of *sod* genes that are consistent with ROS-related roles in signaling. As described above, *sod-3* expression is induced by a variety of stresses. However, the four following considerations suggest that this is not because of an increased need for O~2~^•−^ detoxification but is more likely part of a stress response signaling pathway: (1) It is unclear that all the conditions that up-regulate *sod-3* described above also increase oxidative stress. (2) There is very little evidence that the SOD-3 protein accumulates in amounts that are consistent with a role in detoxification. For example, *sod-3* transcripts but not SOD-3 protein levels are up-regulated in *daf-2* mutants ([@bib41]; [@bib40]). Similarly, the massive up-regulation of *sod-3* that is observed in dauer larvae contributes very little or nothing to overall SOD activity ([@bib41]). (3) Loss of SOD-3 increases the lifespan of the insulin-signaling mutant *daf-2* and suppresses the shortened lifespan of *daf-2; sod-2* double mutants ([@bib81]). It was also demonstrated that, at least in *daf-2* mutants, *sod-2* and *sod-3* are expressed in fully distinct subsets of cells. They therefore concluded that SOD-3 and SOD-2 are involved in a ROS signal that functions in intercellular communication and that regulates longevity. (4) Despite the fact that neither decreasing ([@bib41]; [@bib81]; [@bib191]) nor increasing ([@bib76]) *sod-3* expression has any effect on lifespan, the expression of a *sod-3::gfp* reporter is reported as being the best predictor of remaining lifespan from a collection of genes whose expression is age dependent ([@bib156]). Possibly, this means that *sod-3* is coregulated with other genes that affect lifespan or that it is the combined effect of these coregulated genes that can affect lifespan.

There is also a very interesting study on cell-specific up-regulation of *sod-1* ([@bib82]). [@bib82] show that *sod-1* expression is specifically induced in the gustatory neuron ASER in response to pathogenic bacteria and that this up-regulation is required to mediate pathogen avoidance. [@bib82] interpret these findings to suggest that pathogen-induced ROS activate a *sod-1*--dependent pathway to mediate the avoidance behavior. SODs have also been shown to be required in a developmental context: the development of the vulva, which is regulated by the RAS signaling pathway. RAS signaling has been shown to be regulated by ROS in a variety of organisms. In *C. elegans*, RNAi knockdown of *sod-1* or *sod-4* down-regulates RAS signaling in a Ras gain-of-function mutant, suggesting that the RAS pathway is down-regulated by O~2~^•−^ or the absence of H~2~O~2~ in the context of vulval development ([@bib166]).

Drosophila {#s13}
----------

### SOD enzymes in *Drosophila* and their expression {#s14}

In *Drosophila*, there are three genes that encode SOD (Table S1; [@bib102]). *Sod1* and *Sod3* encode Cu/Zn SODs, and *Sod2* encodes an Mn SOD. It has been shown experimentally that SOD1 and SOD2 confer protection from oxidative stress specifically in their respective compartments, i.e., the cytosol and the mitochondria ([@bib124]). *Sod3* is extracellular ([@bib95]). Like for the *C. elegans* extracellular SOD (SOD-4), there are two isoforms of *Sod3* in *Drosophila*, so that in addition to the extracellular form, there is also predicted to be a form that is membrane associated ([@bib13]). The *Drosophila* genome also contains an insect-specific SOD-related gene *Sodesque* (*Sodq*), which is related to the extracellular Cu/Zn SOD family but has lost critical residues required for SOD enzymatic activity, as well as a member of another conserved family of proteins related to Cu/Zn SOD, Related to Sod (*Rsod*), whose function is unknown ([@bib102]).

### Induction of sod genes in *Drosophila* {#s15}

Although there are not strictly inducible *Sod* genes in *Drosophila*, up-regulation of SOD activity or expression has been reported in a few contexts. As in *C. elegans*, SOD activity is up-regulated in long-lived insulin/IGF receptor (INR) mutants as well as in mutants of the insulin receptor substrate CHICO. However, in these cases, it is Cu/Zn SOD activity that is elevated, rather than up-regulation of an Mn SOD ([@bib29]; [@bib180]; [@bib97]). However, the up-regulation in activity does not appear to correlate with an increase in resistance to oxidative stress. It has also been shown that the Cu/Zn SOD *Sod3* is up-regulated in a fly model of Aβ-toxicity ([@bib51]). Surprisingly, knocking down *Sod3* by RNAi improved both behavioral phenotypes and survival, suggesting that it may not act simply to reduce oxidative damage, as will be discussed.

There appears to be an interesting interaction between the two Cu/Zn SODs. Half of Cu/Zn SOD activity is lost in homozygous *Sod3* mutants, suggesting it contributes about half the Cu/Zn SOD activity. However, all Cu/Zn SOD activity in lost in homozygous *Sod1* mutants, suggesting some dependence of *Sod3* on *Sod1* ([@bib143]; [@bib13]). Moreover, in the *Sod3^KG06029^* hypomorph mutant, when *Sod3* expression is restored as a result of excision of the KG p-element upstream of the *Sod3* coding sequence, higher mRNA expression was observed for all types of *Sod*, especially *Sod1*, suggesting that their levels may be coregulated, although it is unclear how or why ([@bib13]).

### ROS sensitivity of *Drosophila sod* mutants {#s16}

*Sod1* mutants harboring a point mutation show a complete lack of Cu/Zn activity and display hypersensitivity to oxidative stress induced by PQ, increased rates of DNA damage, and a shortened lifespan ([@bib143]; [@bib153]; [@bib199]). However, a deletion allele is homozygous lethal ([@bib144]; [@bib13]). Similarly, RNAi-mediated knockdown of *Sod2* leads to increased sensitivity to oxidative stress induced by PQ and a dramatic increase in adult-onset mortality ([@bib99]). *Sod2* heterozygotes are viable and also display hypersensitivity to PQ treatment ([@bib47]). However, mutants homozygous for a null allele of *Sod2* suffer from neonatal lethality. Collectively, these results suggest that both *Sod1* and *Sod2* offer protection from oxidative stress. Similarly, mutation of *Sod3* and RNAi knockdown of *Sod3* leads to increased sensitivity to PQ and shortened lifespan ([@bib95]). In contrast, *Sod3* hypomorphic mutants have normal survival but are less sensitive to H~2~O~2~ and PQ. This suggests that at least in some contexts, loss of *Sod3* can somehow confer protection ([@bib13]). Given that mutation of any of the *Sods* can increase ROS sensitivity and shorten lifespan, several studies have examined whether overexpression of *Sod* genes could be beneficial for stress resistance and longevity (see text box).

### Roles for SOD in Ros signaling in *Drosophila* {#s17}

Similar to the situation in *C. elegans*, there are few studies that have directly addressed the roles of ROS in signaling in vivo in *Drosophila*. However, some of the phenotypes of the *Sod* mutants are suggestive of ROS functions in signaling. For example, mutants carrying a particular reduction-of-function missense mutation of *Sod2* exhibit increased mitochondrial ROS and sensitivity to hyperoxia as well as behavioral defects, defects in axonal targeting, and neurodegeneration ([@bib22]). Although some of these phenotypes could be caused by ROS toxicity, it is likely that specific neural phenotypes like impairments of axon targeting arise from aberrant intracellular signaling caused by increased mitochondrial O~2~^•−^. Similarly, it is difficult to imagine how loss of the extracellular *Sod3* can be protective both in an Aβ toxicity model ([@bib51]) and to H~2~O~2~ and ROS generators like PQ ([@bib13]) unless it also serves to regulate some cellular functions in response to ROS levels rather than protect from superoxide damage.

Mouse {#s18}
-----

### Mammalian SOD enzymes {#s19}

There are three known SOD isoforms in mammals (Table S1). The Cu/Zn SOD SOD1 is the cytoplasmic isoform but has also been identified in the nucleus, lysosome, peroxisome, and the mitochondrial intermembrane space ([@bib24]; [@bib34]; [@bib134]). The Mn SOD SOD2 localizes to the mitochondrial matrix ([@bib168]). Although complex I superoxide is released nearly exclusively to the mitochondrial matrix, complex III generates superoxide not only to the matrix but also outward to the inner membrane space, where it becomes a substrate for SOD1 ([@bib130]; [@bib78]). The Cu/Zn SOD SOD3 is secreted into the extracellular space ([@bib65]). SOD1 is most abundant in most tissues, with a surprisingly high cellular concentration (estimated to be 10--40 µM; [@bib24]; [@bib7]). SOD1 and SOD2 are expressed in practically all cells. High expression of *Sod3* was identified in selected tissues, particularly in blood vessels, lung, kidney, and heart ([@bib117]; [@bib58]; [@bib173]; [@bib50]). SOD3 can also be inducible in other tissues, which we will discuss.

### Lethality of Sod2 knockout mice {#s20}

As valuable tools to study ROS metabolism, an extensive collection of *Sod* mutant mice has been generated and characterized (Table S2). Loss of a single copy of *Sod2* (*Sod2^+/−^*) does not produce any overt pathology except for increased incidence of cancer in old age ([@bib110]; [@bib105]; [@bib194]). Close examination revealed that *Sod2^+/−^* mutants display higher levels of oxidative damage, susceptibility to oxidative stress, inhibition of mitochondrial function, and premature initiation of apoptosis, yet exhibit close-to-normal lifespans ([@bib110]; [@bib105]; [@bib100]; [@bib193], [@bib194]). Along the same lines, several studies showed that increased SOD2 expression is associated with a reduction of mitochondrial O~2~^•−^ levels, attenuated age-dependent increase of oxidative damage, and better preservation of mitochondrial function especially in old age ([@bib167]; [@bib84]; [@bib106]). Despite this, increased SOD2 expression had little or no effect on lifespan ([@bib84]; [@bib91]).

To study the requirement for SOD2 in vivo, several conditional knockout lines have already been created (Table S2). Among those, conditional knockout of *Sod2* in the highly aerobic tissues (e.g., cardiac and skeletal muscles) appears to be most damaging ([@bib132]; [@bib90]). Especially, in contrast with other tissue-specific knockouts of *Sod2*, loss of *Sod2* in the brain is lethal within 3--4 wk after birth, suggesting a particularly high sensitivity of neurons to elevated mitochondrial O~2~^•−^ ([@bib90]).

The exact pathophysiological effects and the resulting animal lethality of loss of mitochondrial SOD are not entirely clear, as superoxide is not a particularly reactive species and its toxicity has been most clearly linked to its transformation into other more toxic species rather than by direct oxidative damage by itself ([@bib11]). Another important and direct target of superoxide is iron--sulfur cluster proteins, which might be particularly relevant for the condition of *Sod2* knockout as many of the mitochondrial respiratory chain enzymes (e.g., succinate dehydrogenase) and TCA enzymes (e.g., aconitase) contain iron--sulfur clusters in their active sites. For example, aconitase has long been recognized as a sensitive index of steady-state superoxide, and loss of mitochondrial aconitase activity has been observed in many conditions where excessive superoxide is expected to be present, including *Sod2* mutants ([@bib132]; [@bib103]; [@bib101]). Finally, reduced NO^•^ bioavailability, in addition to ONOO- accumulation resulting from inefficient superoxide removal in the mitochondria, could significantly impair mitochondrial function ([@bib16]), contributing at least in part to the early lethality of *Sod2* null mice.

### Phenotypes associated with loss of Sod1 and Sod3 in mice {#s21}

In contrast with *Sod2^−/−^* mice, homozygous mutations in the *Sod1* and *Sod3* genes are not lethal but rather appear superficially normal ([@bib145]). *Sod1^−/−^* mice, as expected, showed extensive oxidative damage in the cytoplasm as well as to a lesser extent in the nucleus and mitochondria ([@bib48]). In addition to ∼30% reduction in lifespan, many abnormalities have been reported for *Sod1^−/−^* mice including acceleration of age-dependent skeletal muscle atrophy, hearing loss, delayed wound healing, increase in cellular senescence, locomotor defects, denervation, motor axonopathy, impaired motivational behavior, accelerated age-related macular degeneration, impaired olfactory sexual signaling in the male, and lower female fertility (Table S2; [@bib118]; [@bib57]; [@bib48]; [@bib87]; [@bib128]; [@bib89]; [@bib55]; [@bib208], [@bib209]; [@bib66]; [@bib165]; [@bib206]). *Sod1^−/−^* mice also have increased incidence of hepatocellular carcinoma in old age ([@bib48]).

*Sod3^−/−^* mice under normal conditions develop normally and remain healthy for the majority of their adult lives ([@bib21]). However, under high oxygen pressure (\>99%), they show a significantly shorter survival time than the WT and develop an earlier onset of lung edema ([@bib21]). The lack of SOD3 is also shown to exacerbate angiotensin-induced hypertension, which is likely attributed to a decrease in endothelial NO^•^ bioavailability (see above; [@bib96]). As lung and blood vessels have high amounts of SOD3 expression ([@bib65]), it is not surprising that they are most affected by the loss of SOD3. In contrast with the germline *Sod3* knockout, acute deletion of *Sod3* in adult mice results in severe acute lung injury and death within 7 d of induction of the gene knockout (Table S2; [@bib70]). The striking phenotypic difference between the germline and induced adult-onset knockouts points to the presence of powerful compensatory mechanisms that acts in the conventional *Sod3* knockout model.

Interestingly, in cell culture, the effects of the loss of different *Sod* genes appear to be exactly opposite to those observed in mice. That is, the mouse embryonic fibroblasts isolated from *Sod1^−/−^* mice die a few days after isolation ([@bib189]), whereas *Sod2*^−/−^ mouse embryonic fibroblasts and equivalent human cells can grow and proliferate under normal conditions despite compromised mitochondrial function ([@bib207]; [@bib33]). This phenomenon is not yet understood.

Another type of SOD signaling in mammals {#s22}
========================================

In mammals, Cu/Zn SOD SOD3 (also extracellular SOD \[EcSOD\]) is found in the extracellular matrix of tissues as well as extracellular fluids including the blood ([@bib98]). It is a glycoprotein, and because of its affinity for heparan-sulfate polysaccharides, a portion of SOD3 binds to the glycocalyx of cell surfaces, where it acts on O~2~^•−^ released by the membrane-bound NADPH oxidase ([@bib65]). O~2~^•−^ diffuses poorly across membranes but can penetrate the plasma membrane through anion channels. Thus, both O~2~^•−^ and H~2~O~2~ produced in the extracellular space potentially can travel back into the cells, where they could initiate signaling by interacting with nearby proteins ([@bib56]). It is not yet known what regulatory role SOD3 could have in the cross-membrane signaling.

Because SOD3 is secreted, it potentially can be redistributed via circulation and have an action at a distance. Indeed, a recent study shows that overexpression of SOD3 in skeletal muscles led to significantly elevated SOD3 levels both in the serum and in most of the peripheral tissues, which protected against organ damage and improved animal survival under lipopolysaccharide-induced endotoxemia. Similar beneficial effects were also seen in the parabiotic mice who shared blood with ones that overexpress SOD3 in muscle ([@bib17]). The observed increase of SOD3 protein in peripheral organs could be mainly caused by its accumulation on cell surface; however, internalization by endothelial cells is also possible ([@bib28]). Interestingly, exercise was reported to sufficiently enhance expression of SOD3 in muscle tissues, though the effect appears to depend on exercise mode and intensity ([@bib77]; [@bib210]). Lastly, as mentioned above, altered SOD3 levels could affect NO^•^ availability and endothelial function. Therefore, one possible effect of increased circulating SOD3 that has not been studied is how vascular tone and tissue blood supply are affected, the result of which could significantly impact tissue oxygenation and ultimately viability.

The roles of SODs in human diseases {#s23}
===================================

As SOD enzymes are key player in antioxidant defense, there has long been an interest in their roles in disease and the potential of increasing SOD levels for therapeutic use. In fact, alterations in the expression level or catalytic activity of SODs have been found in a variety of pathological conditions, including some of the most common age-dependent diseases such as cardiovascular diseases, neurodegenerative diseases, and cancer ([@bib114]; [@bib152]). We will briefly discuss a few diseases for which the role of SOD has been studied.

Mutation of SOD1 in ALS {#s24}
-----------------------

The most widely studied connection between SOD and human diseases is ALS, a late-onset fatal neurodegenerative disorder that primarily affects motor neurons ([@bib151]). Mutations in the *SOD1* gene were first identified as a cause of familial ALS in 1993 ([@bib154]). Since then, \>170 different mutations spread throughout the *SOD1* gene have been described to result in ALS, and a general estimate is that *SOD1* mutations account for ∼14--20% of familiar ALS and 1--3% of sporadic cases ([@bib4]; [@bib182]). Although it has been generally accepted that acquisition of a toxic property by mutant SOD1 forms rather than loss or gain of its superoxide scavenging activity is responsible for the manifestation of ALS phenotype, how exactly SOD1 mutations lead to the selective motor neuron death is not yet entirely clear.

SODs in cancer redox signals {#s25}
----------------------------

Oxidative stress has been heavily implicated in many aspects of cancer biology. First, higher ROS level could promote DNA mutations, thus playing a potential causal role in tumorigenesis. After transformation and during tumor maintenance, cancer cells must cope with toxic effects of high oxidative stress and potentially alter their redox homeostasis to support fast growth ([@bib138]). Tumor cells often display enhanced intracellular ROS levels ([@bib162]; [@bib155]). A more recent view is that their increasing ROS production is an adaptive process that tumor cells use to induce changes in signaling pathways beneficial for their normal function. For example, activation of the PI3K/AKT signaling transduction pathway, one of the major targets of ROS, can promote proliferation, metabolic adaption, and cell mobility ([@bib19]; [@bib107]; [@bib142]; [@bib175]). ROS stabilize HIF1α and activate NRF2, and their aberrant activation can facilitate adaptations to hypoxia, stimulate angiogenesis, and enhance cell proliferation ([@bib23]; [@bib163]; [@bib125]). Furthermore, several oncogenes like KRAS and MYC have been linked to increased mitochondrial ROS production ([@bib155]).

It has been shown that many tumor cells also display changes in antioxidant enzyme profiles. For example, alterations in *SOD2* gene expression and/or protein levels have been reported in various types of cancer cells, but some with conflicting results ([@bib75]). This is perhaps not surprising given that the studies dealt with different cancer types, samples at varying stages of metastatic progression, and different detection techniques. It remains to be fully understood how SOD2 contributes to aberrant protumorigenic signaling; however, one point of view particularly noteworthy is that SOD2 activity may change with cell transformation and malignant progression in accordance with the different needs of tumor cells at different stages to maintain their viability and growth advantage ([@bib75]). That is, in the initial onset/proliferative stage of tumor initiation, SOD2 level is low, which may help promote malignant transformation, yet once the tumor progresses to a more aggressive phenotype, SOD2 level/activity is increased, contributing to a mitochondrial H~2~O~2~ increase that, through activation of oncogenic and angiogenic pathways, helps the cell to acquire invasive properties ([@bib75]; [@bib123]). In fact, using transgenic mice expressing a luciferase reporter gene under the control of human *SOD2* promoter and a chemically induced skin tumorigenesis model, a shift in SOD2 expression from low at early stage to high at advanced squamous cell carcinoma was identified ([@bib39]). Furthermore, catalase levels are found to be decreased in some tumor cells, and more notably, catalase overexpression, which is expected to accelerate H~2~O~2~ destruction, was shown to inhibit invasive and migratory phenotype ([@bib31]; [@bib75]). In vitro induction of SOD2 overexpression was shown to slow cancer cell proliferation ([@bib86]), which presumably is mediated by redox-dependent signaling events, though how is not completely clear.

SOD3 in cardiovascular diseases {#s26}
-------------------------------

Because of the key role of SOD3 in modulating O~2~^•-^ levels in the vasculature, this SOD has been linked to pathological conditions that involve vascular dysfunction such as diabetes, hypertension, and atherosclerosis ([@bib65]). Oxidative stress, especially production of O~2~^•-^, is believed to induce endothelial dysfunction, a crucial early step in atherosclerosis ([@bib129]). Furthermore, as previously mentioned, excess O~2~^•-^ itself can directly antagonize NO^•^ by a direct chemical interaction. The endothelium-derived NO^•^ controls the extent of vascular smooth muscle relaxation, inhibits platelet aggregation, and attenuates neutrophil adherence to the endothelium ([@bib186]). SOD3, by opposing inactivation of vascular NO^•^, might therefore be crucial for the maintenance of blood vessel tone and protection against plaque formation. In support of this, decreased SOD3 activity was observed in human atherosclerotic lesions ([@bib64]). In patients with coronary artery disease, the activity of SOD3 was also found to be reduced, whereas SOD1 and SOD2 remain unaffected ([@bib64]).

Hypertension has also been linked to increased vascular oxidative stress. *Sod3^−/−^* mice were shown to display augmented hypertension in response to angiotensin II or development of higher renovascular hypertension after renal artery clipping ([@bib96]; [@bib69]). These findings suggest a role for SOD3 and superoxide in the genesis of hypertension. Interestingly, more recent studies demonstrated that deletion of SOD3 in the circumventricular organs raised basal blood pressure and augmented the hypertension caused by angiotensin II, whereas removal of SOD3 specifically in the vascular smooth muscle showed no effect on blood pressure either at baseline or in response to angiotensin II despite observable effects on vascular O~2~^•-^ and NO^•^ ([@bib112], [@bib113]).

Conclusions {#s27}
===========

It has been well established that ROS and RNS function as important diffusible signaling molecules. Because the SODs are the only enzymes that interact with superoxide specifically and thus control the levels of ROS and RNS, they also serve as key regulators of signaling. Of course, in addition to acting as signaling molecules, at high levels, these reactive species can become toxic. In fact, most attention has focused on their toxic properties because when their levels are dramatically altered, damaging effects become a more obvious phenomenon than alteration in signaling, although the deleteriousness of the loss of SODs might involve both aspects. This is clearly shown by some of the studies in model organisms discussed in this review, where the loss of a particular SOD leads to specific developmental or physiological changes without impairing viability.

Online supplemental material {#s28}
============================

Table S1 show nomenclature and characteristics of SOD enzymes across various species. Table S2 shows *Sod* gene knockout mouse models and their phenotypes.
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